Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms
Conditions
Interventions
Intervention1: Tamsulosin: 0.4 mg capsules orally once daily at bedtime for 8 weeks.
Control Intervention1: Silodosin: 8 mg capsules orally once daily at bedtime for 8 weeks.
Sponsors
Dr Pritkumar HIrani
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with BPH with an age of more than 40 years old come to the outpatient department (OPD), 2. International Prostate Symptom Score (IPSS) score of 8 and above, 3. Maximum flow rate of less than 10 ml/s.
Exclusion criteria
Exclusion criteria: 1. Patients with Neurogenic bladder, Bladder neck contracture, Stricture urethra, Bladder calculi, Active urinary tract infection, Prostate cancer, 2. Hemodynamically unstable patients, 3. Patients having an absolute indication for surgery, 4. Allergic to test drugs, 5. Not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in IPSS score, maximum urinary flow rate, and residual urine volume between Group T and Group S.Timepoint: From baseline to follow-up at 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side effects like dizziness, retrograde ejaculation, postural hypotension, and others reported by patients in both groups.Timepoint: From baseline to follow-up at 8 weeks | — |
Countries
India
Contacts
Public ContactDr Sangita Gupta
Outcome results
None listed